NYSE American - Delayed Quote USD

DSS, Inc. (DSS)

1.7550

-0.0450

(-2.50%)

At close: April 25 at 3:58 PM EDT

1.7900

+0.03

(+1.99%)

After hours: April 25 at 7:58 PM EDT

Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition."

NEW YORK, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Impact Biomedical Inc. (IBIO), in which DSS Inc.(NYSE American: DSS) has a significant investment, is thrilled to announce a milestone in its innovative Laetose™ technology platform. The U.S. Patent and Trademark Office (USPTO) has issued U.S. patent # 11,898,184, entitled "Low Glycemic Sugar Composition" developed within this platform. The Laetose™ technology demonstrates compelling potential in reducing caloric intake and glycemic index in foods, whi

GlobeNewswire 2 months ago

DSS
-2.50%
DSS, Inc. Chairman Chan Acquires 672,173 shares of DSS In Open Market

Chairman of the Board Heng Fai Ambrose Chan Adds 672,173 Shares to Increase Investment in CompanyNEW YORK, Jan. 04, 2024 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS, “Company”), a multinational company operating across four distinct market sectors, announced today a significant investment by its Chairman of the Board, Heng Fai Ambrose Chan. In a strategic move to bolster shareholder confidence and underscore his commitment to the company’s growth. Chairman Chan acquired an additional 672,1

GlobeNewswire 3 months ago

DSS
-2.50%
DSS, Inc. Announces Reverse Split as Part of NYSE American Compliance Plan

NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS, “Company”), a multinational company operating nine (9) diversified business lines developed through strategic acquisitions to build shareholder value through periodic spinoffs to its shareholders, today announced that it will proceed with a 1-for-20 reverse stock split (the “Reverse Split”) of its issued and outstanding shares of common stock, par value $0.02, following authorization by its Board of Directors and majority

GlobeNewswire 4 months ago

DSS
-2.50%
DSS: Q3 2023 Results Show Hesitation from DSS Customers Due to A Worsening Economy and Government Inaction

By Lisa Thompson NYSE:DSS READ THE FULL DSS RESEARCH REPORT DSS (NYSE:DSS) reported Q3 revenues of $4.2 million, down 65% from the year ago’s $11.9 million. Most of the total revenue decline was driven by a $4.4 million decline in Direct Marketing revenues as the company divested Sharing Global Services on May 4th. Direct marketing was down 89% year over year. On April 5th, Sharing was dividended

Zacks Small Cap Research 4 months ago

DSS
-2.50%
Premier Packaging, a Wholly-Owned Subsidiary of DSS, Inc., Secures Contract Extension with Major Retailer Worth Up to $15 Million over Four Years

Option for Fourth Year Brings Potential Revenue to Over $15 MillionNEW YORK, Nov. 28, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating nine (9) diversified business lines developed through strategic acquisitions to build shareholder value through periodic spinoffs to its shareholders, announced today that its wholly-owned subsidiary, Premier Packaging, signed a contract extension with an existing client for the next three years totaling a minimum of $12

GlobeNewswire 4 months ago

DSS
-2.50%
Impact Biomedical Inc. Files Current Report on Form 8-K

Biotechnology Company Currently in Initial Public Offering (IPO) ProcessNEW YORK, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Impact Biomedical, Inc. (“the Company” and “Impact”) announced today that the Company filed a Current Report on Form 8-K with the Securities and Exchange Commission on November 6, 2023, disclosing that DSS BioHealth Security, Inc. (“DBH”), a subsidiary of DSS, Inc. (NYSE American: DSS), converted substantially all of its 87.5% common stock equity interest in Impact into an equivale

GlobeNewswire 5 months ago

DSS
-2.50%
DSS Inc. Wins Patent Dispute with Nichia Corporation

NEW YORK, Nov. 14, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) announced today that, in a unanimous decision, the Court of Appeals for the Federal Circuit (CAFC) rejected Nichia Corp.'s challenge to U.S. Patent No. 6,879,040 (the ‘040 Patent). U.S. Chief Circuit Judge Kimberly Moore, who authored the opinion, and U.S. Circuit Judges Kara Stoll and Tiffany Cunningham sat on the panel for the Federal Circuit. The CAFC appeal mounted by Nichia Corp., a Japanese electronics company, as

GlobeNewswire 5 months ago

DSS
-2.50%
DSS, Inc. Subsidiary Files Current Report on Form 8-K Disclosing Reverse Split of Outstanding and Issued Common Stock and Conversion of Certain Holder’s Common Stock

DSS Shareholders to Benefit from Reduction in Common Stock of Impact BiomedicalNEW YORK, Nov. 08, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) announced today that Impact BioMedical Inc. (“Impact”) filed a Current Report on Form 8-K with the Securities and Exchange Commission on November 6, 2023, disclosing that Impact effected a reverse stock split of its issued and outstanding common stock by a ratio of 1 for 55. Impact did not effectuate a reverse split of its authorized capital st

GlobeNewswire 5 months ago

DSS
-2.50%
DSS Inc. Receives Notice of Non-Compliance with NYSE American Trading Share Price Listing Rule

Company intends to cure the deficiency and return to compliance with NYSE American standardNEW YORK, Oct. 26, 2023 (GLOBE NEWSWIRE) -- DSS, Inc.(NYSE American: DSS) announced today that the Company received a letter (the “Letter”) from the staff of NYSE American LLC (the “Exchange”) stating that the Company’s securities have been selling for a low price per share for a substantial period of time and, pursuant to Section 1003(f)(v) of the NYSE American Company Guide. The Company’s continued listi

GlobeNewswire 5 months ago

DSS
-2.50%
DSS, Inc. Announces Filing of Registration Statement on Form S-1 for Initial Public Offering of Impact Biomedical

NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) -- DSS, Inc.(NYSE American: DSS) ("DSS") announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission ("SEC") relating to the proposed initial public offering of the Company's wholly-owned subsidiary, Impact Biomedical (hyperlink: https://www.impactbiomedinc.com/). DSS, Inc. intends to list Impact Biomedical on the NYSE American exchange. The number of shares of Class A common stock to be offered

GlobeNewswire 5 months ago

DSS
-2.50%
DSS Inc. Issues Letter to Shareholders

CEO Highlights Expected IPO of Impact Biomedical and Progress in SubsidiariesROCHESTER, N.Y., Oct. 12, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating nine (9) diversified business lines developed through strategic acquisitions to build shareholder value through periodic spinoffs to its shareholders, announced today that it has issued a Letter to Shareholders. Dear Valued Shareholders, On behalf of the management team at DSS, Inc., I am pleased to provi

GlobeNewswire 6 months ago

DSS
-2.50%
PRPH
DSS Inc. Expands DSS Wealth Management, Inc.'s Management Team for Ramp Up of Asset Management Subsidiary

Jim Monaghan Appointed Chief Operating Officer and Chief Compliance Officer; Michael Cheah Joins as Portfolio Manager and Head of Fixed IncomeROCHESTER, N.Y., Sept. 06, 2023 (GLOBE NEWSWIRE) -- DSS Wealth Management, Inc., a wholly owned subsidiary of DSS, Inc. and advisor to DSS AmericaFirst Quantitative Funds, is pleased to announce that Jim Monaghan has joined as Chief Operating Officer and Chief Compliance Officer and Michael Cheah has joined DSS Wealth Management in the role of Portfolio Ma

GlobeNewswire 7 months ago

DSS
-2.50%
DSS Cuts Losses Significantly By Exiting Direct Marketing

By Lisa Thompson NYSE:DSS READ THE FULL DSS RESEARCH REPORT Q2 2023 Results and DSS Exits the Direct Marketing Business DSS (NYSE:DSS) reported Q2 revenues of $7.2 million, down 39% from the year ago’s $11.8 million. Most of the total revenue decline was driven by a $4.5 million decline in Direct Marketing revenues as the company divested Sharing Global Services on May 4th. Direct marketing was

Zacks Small Cap Research 7 months ago

DSS
-2.50%
DSS Inc. Announces Distribution Date of August 8, 2023 for Spinoff of Impact BioMedical Inc.

DSS Shareholders of Record on July 10, 2023 to Receive Four Shares of Impact Biomedical Inc. for Every One Share of DSS, Inc.ROCHESTER, N.Y., July 31, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating nine business divisions through strategic acquisitions and development to build shareholder value through periodic spinoffs to shareholders, announced today the distribution date for the previously announced stock dividend of Impact

GlobeNewswire 8 months ago

DSS
-2.50%
DSS Inc. Appoints Daniel Lew as Chief Investment Officer and Portfolio Manager for DSS Wealth, Inc.

ROCHESTER, N.Y., July 05, 2023 (GLOBE NEWSWIRE) -- DSS Wealth, Inc., a wholly owned subsidiary of DSS, Inc. and advisor to DSS AmericaFirst Quantitative Funds, is pleased to announce the appointment of Daniel Lew as Chief Investment Officer and Portfolio Manager. With over three decades of experience in investment management, security analysis, and institutional client advisory, Mr. Lew brings a wealth of knowledge and expertise to his new role. Mr. Lew's distinguished career spans various prest

GlobeNewswire 9 months ago

DSS
-2.50%
DSS Inc. Announces Updated Shareholder of Record Date for Spinoff of Impact BioMedical Inc.

Shareholders of Record on July 10, 2023 to Receive Four Shares of Impact Biomedical Inc. for Every One Share of DSS, Inc. on a Future Distribution DateROCHESTER, N.Y., June 30, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating nine business divisions through strategic acquisitions and development to build shareholder value through periodic spinoffs, has filed for the distribution of a special stock dividend of Impact Biomedical In

GlobeNewswire 9 months ago

DSS
-2.50%
DSS, Inc. Announces Record and Distribution Date for Impact Biomedical Spin-Off Special Dividend

DSS Shareholders of Record on June 30 to Receive 4 Shares for Every 1 DSS ShareROCHESTER, N.Y., June 26, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating nine business divisions through strategic acquisitions and development to build shareholder value through periodic spinoffs, has filed for the distribution of a special stock dividend to DSS Inc. shareholders of record on June 30 for distribution on July 14, 2023. DSS shareholde

GlobeNewswire 9 months ago

DSS
-2.50%
Presenting on the Emerging Growth Conference on June 14 Register Now

MIAMI, June 13, 2023 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 59th Emerging Growth Conference on June 14, 2023. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the conference here. Submit Questions for any of the presenting companies to

GlobeNewswire 10 months ago

DSS
-2.50%
CANSF

DYFSF
DSS: Sharing Services’ Q1 Spin-Off to Be Followed By Impact Biomedical

By Lisa Thompson NYSE:DSS READ THE FULL DSS RESEARCH REPORT DSS (NYSE:DSS) continued to make progress in Q1 to reduce its cash burn by spinning off Sharing Services Global. Although Sharing has not year reported its March quarter we believe it contributed about $3 million in revenues and the same amount in operating expenses to DSS. In Q2 we expect one month of Sharing will be in DSS’ income

Zacks Small Cap Research 11 months ago

DSS
-2.50%
DSS, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023

ROCHESTER, N.Y., May 16, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating nine business divisions through strategic acquisitions and development to build shareholder value through periodic spinoffs, announced today its financial results for the First Quarter, 2023. Selected Financial Highlights Premier Packaging revenue increased 72% - Revenue from sales of printed products increased 72% during the 3 months ended March 31, 2023,

GlobeNewswire 11 months ago

SHRG

DSS
-2.50%

Performance Overview

Return	DSS	S&P 500
YTD	-26.88%	+5.84%
1-Year	-57.04%	+22.03%
3-Year	-96.76%	+20.77%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

DSS, Inc. (DSS)

Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition."

DSS, Inc. Chairman Chan Acquires 672,173 shares of DSS In Open Market

DSS, Inc. Announces Reverse Split as Part of NYSE American Compliance Plan

DSS: Q3 2023 Results Show Hesitation from DSS Customers Due to A Worsening Economy and Government Inaction

Premier Packaging, a Wholly-Owned Subsidiary of DSS, Inc., Secures Contract Extension with Major Retailer Worth Up to $15 Million over Four Years

Impact Biomedical Inc. Files Current Report on Form 8-K

DSS Inc. Wins Patent Dispute with Nichia Corporation

DSS, Inc. Subsidiary Files Current Report on Form 8-K Disclosing Reverse Split of Outstanding and Issued Common Stock and Conversion of Certain Holder’s Common Stock

DSS Inc. Receives Notice of Non-Compliance with NYSE American Trading Share Price Listing Rule

DSS, Inc. Announces Filing of Registration Statement on Form S-1 for Initial Public Offering of Impact Biomedical

DSS Inc. Issues Letter to Shareholders

DSS Inc. Expands DSS Wealth Management, Inc.'s Management Team for Ramp Up of Asset Management Subsidiary

DSS Cuts Losses Significantly By Exiting Direct Marketing

DSS Inc. Announces Distribution Date of August 8, 2023 for Spinoff of Impact BioMedical Inc.

DSS Inc. Appoints Daniel Lew as Chief Investment Officer and Portfolio Manager for DSS Wealth, Inc.

DSS Inc. Announces Updated Shareholder of Record Date for Spinoff of Impact BioMedical Inc.

DSS, Inc. Announces Record and Distribution Date for Impact Biomedical Spin-Off Special Dividend

Presenting on the Emerging Growth Conference on June 14 Register Now

DSS: Sharing Services’ Q1 Spin-Off to Be Followed By Impact Biomedical

DSS, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023

Performance Overview